Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are three stocks where Wall Street’s positive outlook is supported by strong fundamentals.

BioMarin Pharmaceutical (BMRN)

Consensus Price Target: $94.80 (73.9% implied return)

Pioneering treatments for conditions that often had no previous therapeutic options, BioMarin Pharmaceutical (NASDAQ: BMRN) develops and commercializes therapies that address the root causes of rare genetic disorders, particularly those affecting children.

Why Are We Positive On BMRN?

1. Market share has increased this cycle as its 17.1% annual revenue growth over the last two years was exceptional
2. Incremental sales significantly boosted profitability as its annual earnings per share growth of 22.2% over the last five years outstripped its revenue performance
3. Free cash flow margin expanded by 13.6 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends

BioMarin Pharmaceutical is trading at $54.50 per share, or 14.3x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free for active Edge members.

First BanCorp (FBP)

Consensus Price Target: $25.33 (26.8% implied return)

Tracing its roots back to 1948 in San Juan, First BanCorp (NYSE: FBP) is a bank holding company that provides commercial banking, consumer financing, mortgage services, and insurance products across Puerto Rico, the U.S. mainland, and the Caribbean.

Why Is FBP a Good Business?

1. Differentiated product suite is reflected in its Strong performance of its loan book leads to a High-yielding loan book and low cost of funds lead to a premier net interest margin of 4.5%
2. Share buybacks catapulted its annual earnings per share growth to 8.8%, which outperformed its revenue gains over the last two years
3. Impressive 27.9% annual tangible book value per share growth over the last two years indicates it’s building equity value this cycle

At $19.98 per share, First BanCorp trades at 1.7x forward P/B. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.

First Citizens BancShares (FCNCA)

Consensus Price Target: $2,187 (24.5% implied return)

With roots dating back to 1898 and a significant expansion through its 2023 acquisition of Silicon Valley Bank, First Citizens BancShares (NASDAQGS:FCNC.A) is a bank holding company that provides financial services to individuals and businesses through its First-Citizens Bank & Trust Company subsidiary.

Why Could FCNCA Be a Winner?

1. Annual net interest income growth of 37.7% over the last five years was superb and indicates its market share increased during this cycle
2. Earnings growth has trumped its peers over the last two years as its EPS has compounded at 7.3% annually
3. Impressive 36.7% annual tangible book value per share growth over the last five years indicates it’s building equity value this cycle

First Citizens BancShares’s stock price of $1,756 implies a valuation ratio of 1x forward P/B. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free for active Edge members .

High-Quality Stocks for All Market Conditions

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.